Comment on

• Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.

  File TM, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, Seltzer E, Paukner S, Wicha WW, Talbot GH, Gasink LB. File TM, et al. Clin Infect Dis. 2019 Nov 13;69(11):1856-1867. doi: 10.1093/cid/ciz090. Clin Infect Dis. 2019. PMID: 30722059 Free PMC article. Clinical Trial.
• Lefamulin for Treating Community-acquired Bacterial Pneumonia in Adult Patients Aged <65 Years.

  Tang HJ, Lai CC. Tang HJ, et al. Clin Infect Dis. 2020 Sep 12;71(6):1582. doi: 10.1093/cid/ciz1173. Clin Infect Dis. 2020. PMID: 31822903 No abstract available.